BERNARDI, MAURO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.758
AS - Asia 3.610
EU - Europa 1.800
SA - Sud America 579
AF - Africa 101
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 12.856
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.657
SG - Singapore 1.146
HK - Hong Kong 803
CN - Cina 657
VN - Vietnam 450
BR - Brasile 421
GB - Regno Unito 349
SE - Svezia 296
FI - Finlandia 261
RU - Federazione Russa 174
IT - Italia 160
DE - Germania 118
KR - Corea 107
BG - Bulgaria 92
FR - Francia 70
IN - India 67
AR - Argentina 63
BD - Bangladesh 60
CA - Canada 45
NL - Olanda 45
IQ - Iraq 41
JP - Giappone 38
ID - Indonesia 37
ZA - Sudafrica 37
AE - Emirati Arabi Uniti 35
MX - Messico 31
PL - Polonia 30
UA - Ucraina 30
IE - Irlanda 28
TR - Turchia 27
AT - Austria 25
BE - Belgio 23
PK - Pakistan 23
CO - Colombia 19
ES - Italia 19
CL - Cile 17
EC - Ecuador 17
MY - Malesia 14
VE - Venezuela 14
CZ - Repubblica Ceca 13
DZ - Algeria 13
EG - Egitto 13
LT - Lituania 13
SA - Arabia Saudita 13
PY - Paraguay 12
KE - Kenya 10
UZ - Uzbekistan 10
IR - Iran 9
KZ - Kazakistan 9
MA - Marocco 9
IL - Israele 8
PH - Filippine 8
AZ - Azerbaigian 7
ET - Etiopia 7
JO - Giordania 7
NO - Norvegia 7
RO - Romania 7
UY - Uruguay 7
DO - Repubblica Dominicana 6
PE - Perù 6
TN - Tunisia 6
CH - Svizzera 5
CR - Costa Rica 5
DK - Danimarca 5
RS - Serbia 5
AU - Australia 4
BY - Bielorussia 4
NP - Nepal 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AL - Albania 3
BO - Bolivia 3
HN - Honduras 3
HU - Ungheria 3
KG - Kirghizistan 3
LB - Libano 3
LK - Sri Lanka 3
MD - Moldavia 3
OM - Oman 3
CY - Cipro 2
EE - Estonia 2
GE - Georgia 2
GR - Grecia 2
GT - Guatemala 2
LV - Lettonia 2
MK - Macedonia 2
PR - Porto Rico 2
PS - Palestinian Territory 2
QA - Qatar 2
SV - El Salvador 2
TH - Thailandia 2
TW - Taiwan 2
AM - Armenia 1
AO - Angola 1
CD - Congo 1
CI - Costa d'Avorio 1
CV - Capo Verde 1
DM - Dominica 1
GD - Grenada 1
HR - Croazia 1
JM - Giamaica 1
Totale 12.843
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.120
Hong Kong 797
Singapore 754
Ashburn 751
Fairfield 552
Chandler 548
Helsinki 255
Nyköping 255
San Jose 225
London 219
Woodbridge 208
Houston 197
Wilmington 193
Seattle 166
Cambridge 159
Ann Arbor 148
Beijing 145
Ho Chi Minh City 139
Los Angeles 121
Hanoi 116
The Dalles 116
San Diego 114
Seoul 106
Chicago 105
New York 102
Council Bluffs 91
Sofia 91
Princeton 90
Hefei 60
Salt Lake City 50
Orem 49
Buffalo 47
Moscow 47
São Paulo 44
Southend 41
Shanghai 40
Bremen 33
Jersey City 30
Dallas 29
Dearborn 28
Da Nang 27
Tokyo 27
Dublin 26
Brussels 23
Johannesburg 23
Tampa 23
Haiphong 22
Jakarta 22
Warsaw 22
Chennai 21
Redondo Beach 21
Frankfurt am Main 18
Amsterdam 17
Phoenix 17
Toronto 16
Milan 14
Rio de Janeiro 14
San Francisco 14
Elk Grove Village 13
Groningen 13
Lauterbourg 13
Paris 13
Vienna 13
Atlanta 12
Biên Hòa 12
Bologna 12
Brno 12
Manchester 12
Stockholm 12
Brooklyn 11
Detroit 11
Mexico City 11
Norwalk 11
Denver 10
Falkenstein 10
Jacksonville 10
Montreal 10
Nairobi 10
Rome 10
Vancouver 10
Baghdad 9
Belo Horizonte 9
Buenos Aires 9
Curitiba 9
Kilburn 9
Modena 9
Nuremberg 9
Sterling 9
Des Moines 8
Dhaka 8
Guangzhou 8
Newark 8
Santiago 8
Tashkent 8
Addis Ababa 7
Dulles 7
Montevideo 7
Poplar 7
San Mateo 7
Santo André 7
Totale 9.161
Salva come PNG Salva come JPEG
Nome #
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 338
A new prognostic model to predict dropout from the waiting list in cirrhotic candidates for liver transplantation with MELD score <18. 301
Imbalance of Neutrophils and Lymphocyte Counts Can Be Predictive of Hepatocellular Carcinoma Occurrence in Hepatitis C-related Cirrhosis Treated With Direct-acting Antivirals 278
AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions 264
Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice 252
Metronomic capecitabine as second-line treatment for hepatocellular carcinoma after sorafenib discontinuation 240
Adaptive response in Hepatitis B virus infection 231
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation 215
Alopecia universalis after discontinuation of pegylated interferon and ribavirin combination therapy for hepatitis C: a case report 213
Development of different psychiatric manifestations during antiviral therapy for chronic hepatitis C. 202
CD 133+ stem cells for the treatment of end stage liver disease 198
A new approach to the use of α-fetoprotein as surveillance test for hepatocellular carcinoma in patients with cirrhosis 192
A randomized trial of induction doses of interferon alone or in combination with ribavirin or ribavirin plus amantadine for treatment of non-responder patients with chronic hepatitic C 191
Alcohol and viral hepatitis: a mini-review 190
Chronic hepatitis B: Are we close to a cure? 184
C-11 Acetate does not enhance usefulness of F-18 FDG PET/CT in differentiating between focal nodular hyperplasia and hepatic adenoma 184
Acquired intestinal lymphangiectasia successfully treated with a low fat and MCT-enriched diet in a patient with liver transplantation 182
An in-depth psychosocial and biochemical evaluation in transplant recipients for alcoholic liver disease should be planned 175
Calcineurin inhibitors levels reduction during treatment with Sofosbuvir in liver transplanted patients 172
Allocation priority in non urgent liver transplantation: an overview of proposed scoring systems 171
Comparing and combining gamma-hydroxybutiric acid (GHB) and naltrexone in maintaining abstinence from alcohol: an open randomized comparative study 171
Anti-HBs re-seroconversion after liver transplantation in a patient with past HBV infection receiving a HBsAg positive graft 170
Antibodies against pegylated interferon-alpha affect response to treatment in patients with chronic hepatitis C 167
Characterization of a stereotypical cellular and extracellular adult liver progenitor cell niche in rodents and diseased human liver 162
In vitro effect of indomethacin and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C 153
Stem cell mobilization and collection in patients with liver cirrhosis 152
Liver transplantation for hepatocellular carcinoma in clinical practice: the lesson from a 20-year multicentre experience in Italy 151
Bone marrow derived stem cells for the treatment of end-stage liver disease 150
Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance 149
Surveillance for hepatocellular carcinoma in elderly italian patients with cirrhosis. Effects on cancer staging and patients survival 149
Is female sex a significant favorable prognostic factor in hepatocellular carcinoma? 149
Cytokine profile of peripheral blood mononuclear cells from patients with different outcomes of hepatitis C virus infection 148
In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with eAg-negative chronic hepatitis B 145
Ketoprofen, peginterferon-alpha2a and ribavirin for genotype 1 chronic hepatitis C: a phase II study 144
Liver transplantation for patients with alcoholic liver disease: an open question 144
Six score systems to evaluate candidates with advanced cirrhosis for orthotopic liver transplant: which is the winner? 144
Genetic variability of hepatitis C virus in HBV/HCV co-infection and HCV single-infection 142
Liver transplantation from hepatitis B surface antigen positive donors: a safe way to expand the donor pool 142
MARS and Prometheus: our clinical experience in acute chronic liver failure 142
Virus-specific immune response in HBeAg-negative chronic hepatitis B: relationship with clinical profile and HBsAg serum levels 141
Mobilization of bone marrow-derived hematopoietic and endothelial stem cells after orthotopic liver transplantation and liver resection 139
Hepatitis B virus and immune response 136
Polymorphism rtQ215H in primary resistance to adefovir dipivoxil in hepatitis B virus infection: a case report 136
Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B 135
Review article: Alcoholic liver disease - Pathophysiological aspects and risk factors 134
Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study 133
Hepatitis C virus recurrence after liver transplantation: a 10-year evaluation 133
Trattamento dell’epatopatia alcolica 130
Genetic heterogeneity of hepatitis C virus in HBV/HCV co-infection 130
Relationship between hepatic hemodynamics assessed by Doppler ultrasound and liver stiffness 130
Hepatitis C in the elderly: a multicenter cross-sectional study by the Italian Association for the Study of the Liver 128
Hepatocellular carcinoma in patients with cryptogenic cirrhosis 128
Pegylated interferon plus ribavirin for recurrent Hepatitis C infection after liver transplantation in naive and non-responder patients on a stable immunosuppressive regimen 127
Reinfusion of highly purified CD133+ bone marrow-derived stem/progenitor cells in patients with end-stage liver disease: a phase I clinical trial 125
Human herpesvirus-8-related Kaposi’s sarcoma after liver transplantation successfully treated with cidofovir and liposomal daunorubicin 125
High incidence of allograft dysfunction in liver transplant patients treated with PEG-Interferon alfa-2b and Ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis? 119
Serum hepatitis B surface antigen monitoring in long-term Lamivudine-treated hepatitis B virus patients 118
Virological analysis, genotypes and mutational patterns of the HBV pre-core/core gene in HBV/HCV-related hepatocellular carcinoma 116
The pharmacology and activity of non-steroidal anti-inflammatory drugs (NSAIDs): a review of their use as an adjuvant treatment in patients with HBV and HCV chronic hepatitis 116
Hepatocellular carcinoma appearance in patients with hepatitis C virus-related chronic liver disease 90 and 70 months after sustained virological response to interferon and ribavirin 114
Vitamin E for the treatment of E-antigen-positive chronic hepatitis B in paediatric patients: results of a randomized phase 2 controlled study 113
OUTCOME OF LIVER TRANSPLANT FOR ALCOHOLIC LIVER DISEASE 112
Two yr mycophenolate mofetil plus low-dose calcineurin inhibitor for renal dysfunction after liver transplant 112
The increase of Ribavirin dose improves sustained virological response in HCV-Genotype 1 patients with a partial response to PEG-Interferon and Ribavirin. 112
Transient elastography in healthy subjects and factors influencing liver stiffness in non-alcoholi fatty liver disease: an Italian community-based population study 112
Role of Contrast-Enhanced Ultrasonography in Primary Hepatic Lymphoma 111
Immunological modifications during treatment with thymosin alpha 1 plus antiviral therapy in chronic hepatitis C 109
Transcatheter arterial chemoembolization therapy for patients with hepatocellular carcinoma: a case controlled study 109
MUTATIONAL ANALYSIS OF THE HBV PRE-CORE/CORE GENE IN HBV/HCV-RELATED HEPATOCELLULAR CARCINOMA 107
Vitamins in the treatment of chronic viral hepatitis 105
Thymosin-alpha 1 plus interferon-alpha for naive patients with chronic hepatitis C: results of a randomized controlled pilot trial 105
Hepatitis C Virus-related chronic liver disease in elderly patients: an Italian cross-sectional study 105
Post-transplantation lymphoproliferative disorders in liver transplanted patients: a report of four cases 103
Stem cells for end stage liver disease: How far have we got? 102
High risk of hepatocellular carcinoma in anti-HBe positive liver cirrhosis patients developing Lamivudine resistance 101
Patterns of HCV-RNA and HCV core antigen in the early monitoring of standard treatment for chronic hepatitis C 100
GRANULOCYTE COLONY STIMULATING FACTOR (G-CSF) ADMINISTRATION IN CIRRHOTIC PATIENTS: A PHASE II STUDY EVALUATING TOLERABILITY PROFILE AND MOBILIZATION OF HAEMATOPOIETIC STEM CELLS (HSCS) 99
Tenofovir-induced Fanconi syndrome in a patient with chronic hepatitis B monoinfection 99
Hepatic artery stenosis in liver transplanted patients treated with pegylated Interferon alpha-2b and Ribavirin 99
Low replication and variability of HBV pre-core in concomitant infection with hepatitis B and hepatitis C viruses 99
Cryoglobulinemia in elderly patients with HCV-related chronic hepatitis 99
ECHO-COLOUR-DOPPLER CHARACTERIZATION OF CIRRHOTIC PATIENTS RESPONDERS AND NON-RESPONDERS TO NADOLOL AS PRIMARY PROPHYLAXIS 97
Effect of liver transplantation on tuftsin activity and phagocytic activity of neutrophyl granulocytes in patients with liver cirrhosis 97
In portal hypertensive cirrhotic patients abdominal porto-systemic collaterals at ultrasound identify a group of patients at high risk of death 97
OUTCOME OF LIVER TRANSPLANT FOR ALCOHOLIC LIVER DISEASE 93
Sustained and focused HBV-nucleocapsid-specific T cell immunity in liver transplant recipients compared to individuals with chronic and self-limited HBV infection 93
Hepatitis C virus (HCV) infection in elderly patients: A multicenter Italian cross-sectional study 91
PEGYLATED INTERFERON PLUS RIBAVIRIN FOR THE TREATMENT OF RECURRENT HCV INFECTION AFTER LIVER TRANSPLANTATION 90
Evolution of hepatitis C vitus non structural 5A gene (NS5A) in the progression of liver disease to hepatocellular carcinoma 90
Vitamin E as treatment for chronic viral hepatitis: is it time to perform large clinical trials? 77
Totale 12.978
Salva come PNG Salva come JPEG
Categoria #
all - tutte 67.943
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.943
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021331 0 0 0 0 0 0 0 0 0 30 272 29
2021/20221.484 257 134 48 25 11 86 90 85 207 185 193 163
2022/20231.378 188 174 101 137 160 225 11 126 174 4 44 34
2023/2024778 26 47 33 79 217 22 44 122 28 18 28 114
2024/20253.171 117 23 6 238 839 492 116 252 327 178 221 362
2025/20264.926 260 114 387 630 831 439 716 441 576 532 0 0
Totale 12.978